To bridge or not to bridge, that is the question.
Spyropoulos
A C
AC
D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D019990:Perioperative Care; D019106:Postoperative Hemorrhage / Q000139:chemically induced*; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control*; D014812:Vitamin K / Q000009:adverse effects* / Q000037:antagonists & inhibitors / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K